Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis

PURPOSE: Patients with immunoglobulin light chain amyloidosis (AL amyloidosis) generally present with advanced organ dysfunction and have a high risk of early death. We sought to characterize monoclonal immunoglobulin (M-Ig) light chains before clinical presentation of AL amyloidosis. PATIENTS AND M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Weiss, Brendan M., Hebreo, Joseph, Cordaro, Daniel V., Roschewski, Mark J., Baker, Thomas P., Abbott, Kevin C., Olson, Stephen W.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2014
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145182/
https://ncbi.nlm.nih.gov/pubmed/25024082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.50.0892
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars